Helperby Therapeutics
PrivateLast Round
Strategic
Mar 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Helperby Therapeutics operates in Healthcare & Life Sciences and is based in London. It was founded in 2002.
Helperby Therapeutics is a biopharmaceutical company that develops novel antibiotic combination therapies to combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helperby Therapeutics Comparables
Compare Helperby Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdjuTec Pharma AS | 87% | |
| VenatoRx Pharmaceuticals | 84% | |
| QureTech Bio | 82% |
For institutional investors. Book with your work email.
Helperby Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM.
- Jul 25, 2026
Monthly visitors increased 452% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Helperby Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Helperby Therapeutics's valuation, stock price, and market status.
Is Helperby Therapeutics a public or private company?
Helperby Therapeutics is a private company.
What is the current stock price of Helperby Therapeutics?
Helperby Therapeutics is a private company, so its shares have no public market price. Caplight tracks Helperby Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Helperby Therapeutics worth (valuation)?
Valuation information for Helperby Therapeutics is not publicly available.
Can I buy Helperby Therapeutics stock?
Helperby Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Helperby Therapeutics's last funding round?
Helperby Therapeutics's most recent funding round was Strategic on March 17, 2025.
Who are the main investors in Helperby Therapeutics?
Investor information for Helperby Therapeutics is not publicly disclosed.
Will Helperby Therapeutics IPO soon?
No public IPO plans have been announced for Helperby Therapeutics.
How can I track Helperby Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Helperby Therapeutics's shares on secondary markets.